688265 南模生物
按盤價 
24.350 -1.250 (-4.883%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.749 | -1.175 | -0.304 | 5.971 | 22.830 |
| 總資產報酬率 ROA (%) | -0.653 | -1.016 | -0.269 | 5.244 | 15.479 |
| 投入資產回報率 ROIC (%) | -0.676 | -1.056 | -0.280 | 5.550 | 15.292 | 邊際利潤分析 |
| 銷售毛利率 (%) | 43.308 | 42.378 | 41.744 | 60.865 | 58.144 |
| 營業利潤率 (%) | -15.674 | -8.130 | -5.404 | 24.649 | 24.928 |
| 息稅前利潤/營業總收入 (%) | -14.554 | -7.195 | -5.618 | 25.096 | 24.634 |
| 淨利潤/營業總收入 (%) | -15.551 | -5.615 | -1.782 | 22.110 | 22.711 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 129.493 | 132.267 | 226.040 | 88.892 | 89.738 |
| 價值變動淨收益/利潤總額(%) | -42.195 | -60.227 | -123.878 | 3.300 | 5.328 |
| 營業外收支淨額/利潤總額(%) | -0.106 | 0.342 | -11.260 | 1.765 | -0.064 | 償債能力分析 |
| 流動比率 (X) | 6.806 | 6.479 | 7.471 | 12.220 | 2.317 |
| 速動比率 (X) | 6.705 | 6.391 | 7.369 | 12.116 | 2.193 |
| 資產負債率 (%) | 12.494 | 13.064 | 14.012 | 9.185 | 28.594 |
| 帶息債務/全部投入資本 (%) | 5.588 | 5.458 | 5.177 | 3.410 | -- |
| 股東權益/帶息債務 (%) | 1,616.568 | 1,654.962 | 1,726.534 | 2,776.211 | 549.267 |
| 股東權益/負債合計 (%) | 700.376 | 665.472 | 613.699 | 988.743 | 249.720 |
| 利息保障倍數 (X) | -13.188 | -7.474 | 7.381 | 6,302.691 | -88.555 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 128.081 | 98.544 | 87.968 | 70.610 | 0.000 |
| 存貨周轉天數 (天) | 31.280 | 28.064 | 32.751 | 44.717 | 0.000 |
| 備註： | 即時報價更新時間為 03/06/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
